CD36 and metabolic dysfunction-associated steatotic liver disease: Elevated hepatic CD36 levels are observed in HFD-induced MASLD models [12,32], while hepatocyte-specific CD36 deletion attenuates fatty acid uptake and protects against steatosis [33,34].